Top Page
Sekisui Chemical Co
(OTC:4204)
Sekisui Chemical Co (4204) vs. iShares MSCI Japan ETF (EWJ)
Sekisui Chemical Co Business Overview & Revenue Model
Sekisui Chemical Co Earnings Call Summary
Sekisui Chemical Co Financial Statement Overview
| Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.30T | 1.26T | 1.24T | 1.16T | 1.06T |
| Gross Profit | 420.61B | 392.19B | 377.24B | 355.95B | 330.39B |
| EBITDA | 174.77B | 165.25B | 150.80B | 137.58B | 116.65B |
| Net Income | 81.92B | 77.93B | 69.26B | 37.07B | 41.54B |
Balance Sheet | |||||
| Total Assets | 1.33T | 1.32T | 1.23T | 1.20T | 1.15T |
| Cash, Cash Equivalents and Short-Term Investments | 142.59B | 138.57B | 101.08B | 144.53B | 87.45B |
| Total Debt | 110.83B | 120.72B | 120.46B | 122.56B | 138.17B |
| Total Liabilities | 495.42B | 502.32B | 495.61B | 496.17B | 455.75B |
| Stockholders Equity | 807.35B | 792.33B | 705.03B | 674.64B | 667.07B |
Cash Flow | |||||
| Free Cash Flow | 61.13B | 46.18B | 15.14B | 60.41B | 13.20B |
| Operating Cash Flow | 119.23B | 106.63B | 71.54B | 105.02B | 75.27B |
| Investing Cash Flow | -61.51B | -18.52B | -59.43B | 2.69B | -58.49B |
| Financing Cash Flow | -61.20B | -53.02B | -62.91B | -54.73B | -19.16B |
Sekisui Chemical Co Technical Analysis
Sekisui Chemical Co Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | $1.13T | 15.86 | 9.08% | 2.91% | 2.69% | -7.01% | |
62 Neutral | C$7.21B | -0.54 | -4.20% | 2.32% | 11.03% | -29.50% | |
| ― | $2.59B | 12.69 | 14.50% | 180.56% | ― | ― | |
| ― | $1.64B | 11.56 | -19.42% | 3.58% | ― | ― | |
| ― | $28.18B | 9.38 | 14.15% | 4.05% | ― | ― | |
| ― | $2.58B | 10.86 | 11.71% | 3.49% | ― | ― | |
78 Outperform | ¥247.87B | 13.91 | 3.21% | 5.29% | 8.21% |
Sekisui Chemical Co Corporate Events
Sekisui Chemical Co., Ltd. has announced the disposal of treasury shares through a third-party allotment to continue its share-based compensation plan. This move aims to support the Board Incentive Plan Trust and Employee Stock Ownership Plan Trust, enhancing the commitment of directors and executive employees to improve the company’s long-term performance and corporate value. The disposal is expected to have minimal impact on the stock market due to the controlled release of shares, with a dilution effect of only 0.13% of the total issued shares.
The most recent analyst rating on (JP:4204) stock is a Hold with a Yen2600.00 price target. To see the full list of analyst forecasts on Sekisui Chemical Co stock, see the JP:4204 Stock Forecast page.
Sekisui Chemical Co., Ltd. has released its consolidated financial results for the three months ended June 30, 2025, under Japanese GAAP. The company reported a decrease in comprehensive income by 49% compared to the same period last year. Despite this, the company has revised its forecast for consolidated earnings for the first half of the fiscal year, although the full-year forecasts remain unchanged. This announcement may impact stakeholders’ expectations and the company’s market positioning.
The most recent analyst rating on (JP:4204) stock is a Hold with a Yen2540.00 price target. To see the full list of analyst forecasts on Sekisui Chemical Co stock, see the JP:4204 Stock Forecast page.
Sekisui Chemical Co., Ltd. has completed the acquisition of 4,000,000 of its own common shares at a total cost of 9,988,637,250 yen. This move, executed through market buying on the Tokyo Stock Exchange, aligns with the company’s strategic decision to manage its capital structure effectively, potentially enhancing shareholder value.
The most recent analyst rating on (JP:4204) stock is a Hold with a Yen2540.00 price target. To see the full list of analyst forecasts on Sekisui Chemical Co stock, see the JP:4204 Stock Forecast page.
Sekisui Chemical Co., Ltd. has announced the successful acquisition of 3,930,000 of its own common shares through the Tokyo Stock Exchange’s ToSTNeT-3 system, at a total cost of 9,813,210,000 yen. This move is part of the company’s strategy to maintain a flexible capital structure in response to changing business conditions, potentially impacting its market positioning and shareholder value.
The most recent analyst rating on (JP:4204) stock is a Hold with a Yen2540.00 price target. To see the full list of analyst forecasts on Sekisui Chemical Co stock, see the JP:4204 Stock Forecast page.
Sekisui Chemical Co., Ltd. has announced its decision to purchase up to 4,000,000 of its own common shares through the ToSTNeT-3 system of the Tokyo Stock Exchange at a set price of 2,497 yen per share. This strategic move, with a maximum acquisition cost of 9,988,000,000 yen, is part of a broader plan approved by the Board of Directors to enhance shareholder value and optimize capital structure, with the acquisition period extending until March 31, 2026.
The most recent analyst rating on (JP:4204) stock is a Hold with a Yen2540.00 price target. To see the full list of analyst forecasts on Sekisui Chemical Co stock, see the JP:4204 Stock Forecast page.
Sekisui Chemical Co., Ltd. has announced a decision to pay a fiscal year-end dividend of ¥42 per share, maintaining the amount forecasted earlier. This decision aligns with the company’s policy to ensure a dividend payout ratio of 40% or higher and reflects its commitment to shareholder returns. The total dividend for the fiscal year amounts to ¥79 per share, highlighting the company’s stable financial performance and strategic focus on rewarding shareholders.
The most recent analyst rating on (JP:4204) stock is a Hold with a Yen2540.00 price target. To see the full list of analyst forecasts on Sekisui Chemical Co stock, see the JP:4204 Stock Forecast page.